# Triple Quadrupole Mass Spectrometer System with QTRAP Functionality

> **NIH NIH S10** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2024 · $598,969

## Abstract

PROJECT SUMMARY
This proposal requests funds for an integrated mass spectrometry system consisting of SCIEX 7500 triple
quadrupole mass spectrometer with QTRAP functionality (AB Sciex LLC, Framingham, MA USA) along with a
Nexera UPLC (Shimadzu, Kyoto, Japan), SCIEX gas generator, uninterruptible power supply, and workbenches.
The requested instrument will be located in and maintained by the Eicosanoid Core (EC) at Vanderbilt University
Medical Center. This instrument will used to measure bioactive oxidized lipid mediators. Three major users and
four minor users from across three different divisions within the Department of Medicine, the Department of
Ophthalmology and Visual Sciences, and the Vanderbilt University Department of Pharmacology will use mass
spectrometry to study the role of these important signaling molecules in cancer, diabetes, diabetic retinopathy,
cardiovascular disease, hypertension, and more.
The ability to identify and differentiate between many structurally related oxidized lipid mediators at low
concentrations in biological samples is critical to understanding the role of these important signaling molecules
in human physiology and disease response. Due to the carboxylic acid functionality on all oxylipins, these
molecules ionize best in the negative ion mode, but negative ion electrospray MS has traditionally suffered from
low sensitivity. The source design of the SCIEX 7500 has been tailored to enhance ion detection, particularly for
negative ions. Oxidized lipid mediators show peak areas more than 50x higher using the SCIEX 7500 compared
to the previous generation instrument. Test samples sent to SCIEX from the EC detected 48 oxylipins, while only
29 oxylipins were detected using the LC/MS system that is currently leased by the EC. In addition to sensitivity
gains, the SCIEX 7500 is equipped with QTRAP functionality, which adds greater specificity. The QTRAP allows
the third quadrupole in this system to be configured as a Linear Ion Trap. While quantitative data is being
collected using the MRM mode, enhanced product ion scanning can be captured, obtaining structural information
of the detected analyte. This feature is particular useful for the detection and accurate assessment of oxylipins,
as many structurally distinct oxylipins and related metabolites have the same mass-to-charge ratios and similar
structures. The overall added sensitivity and specificity of the SCIEX 7500 will significantly enhance the
capabilities of the users to detect and quantify oxylipins in low-level biological samples.
This location of the EC is in close proximity to the laboratories of many of the users. Dr. Milne, Director of
the EC, is a world-renowned expert in the analysis of oxidized lipid mediators and has extensive training and
experience in mass spectrometry. Personnel in the ECL have combined more than 120 years of experience in
assisting more than 200 investigators worldwide with mass spectrometric analysis of lipid mediators. Instit...

## Key facts

- **NIH application ID:** 10853568
- **Project number:** 1S10OD036357-01
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Ginger Lohr Milne
- **Activity code:** S10 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $598,969
- **Award type:** 1
- **Project period:** 2024-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10853568

## Citation

> US National Institutes of Health, RePORTER application 10853568, Triple Quadrupole Mass Spectrometer System with QTRAP Functionality (1S10OD036357-01). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10853568. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
